Biotech · Private company
Civi Biopharma, Inc.
Track this companyFree. Adds Civi Biopharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Iloprost Injection, for intravenous usePhase 3 · Raynaud's Phenomenon Secondary to Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
- CIVI 007Phase 2 · HypercholesterolemiaClinicalTrials.gov · fetched Nov 12, 2026
- Iloprost Injection, for intravenous usePhase 2 · Raynaud Phenomenon Secondary to Systemic SclerosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Phase 2a Study to Assess CIVI 007 in Patients on a Background of Statin TherapyPHASE2 · COMPLETED · started Nov 11, 2019ClinicalTrials.gov NCT04164888 · fetched Nov 12, 2026
- Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3)PHASE3 · COMPLETED · started Oct 14, 2019ClinicalTrials.gov NCT04040322 · fetched Nov 12, 2026
- Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)PHASE2 · COMPLETED · started Mar 7, 2019ClinicalTrials.gov NCT03867097 · fetched Nov 12, 2026